Appropriateness of oral anticoagulant therapy and associated factors among hospitalized atrial fibrillation patients with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1 (beyond sex). [PDF]
Hailesilase GG +3 more
europepmc +1 more source
Effects of Cedirogant on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates. [PDF]
D'Cunha R +8 more
europepmc +1 more source
Association between atrial fibrillation and gastrointestinal bleeding: pathophysiology, risk stratification, and management - a narrative review. [PDF]
Mohan A +11 more
europepmc +1 more source
Narrative Review of Management Strategies and Risk Mitigation for Gastrointestinal Bleeding in Atrial Fibrillation Patients Receiving Warfarin. [PDF]
Soltani AS +7 more
europepmc +1 more source
Asian Perspectives on Atrial Fibrillation Management: Lessons Learned From the COOL-AF Registry. [PDF]
Krittayaphong R.
europepmc +1 more source
A Very Late Mitral Valve Hypoattenuated Leaflet Thickening With Significant Warfarin Response. [PDF]
Almasri M +4 more
europepmc +1 more source
Direct oral anticoagulants vs. warfarin for left ventricular thrombus. [PDF]
Kassab J +4 more
europepmc +1 more source
Exploring the knowledge level and practices of hospital pharmacists in management of oral anticoagulants in Gulf Cooperation Council countries: a scoping review of literature. [PDF]
Alanazi A +3 more
europepmc +1 more source
Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation. [PDF]
Yang Y +4 more
europepmc +1 more source

